Juniper Networks Inc. (NYSE: JNPR), a provider of networking solutions, was initiated for coverage by Citigroup with a Buy rating and a price target of $38. 

Despite closing at $30.88 on Thursday, the stated price target suggests a potential upside of $7.12 or approximately 23.09% for $JNPR, based on the investment firm's view.

Plus Therapeutics Inc. (Nasdaq: PSTV), a pharmaceutical company, was maintained by HC Wainwright & Co. with a Buy rating and an increased price target of $8 (previously $3.5). 

With $PSTV closing at $2.46 on Thursday, the raised price target implies a potential upside of $5.54 or about 225.20%, according to the investment banking firm 's analysis.

Donnelley Financial Solutions (NYSE: DFIN), a provider of compliance and financial solutions, received coverage initiation from Needham with a Buy rating and a price target of $55. 

Based on Thursday's closing price of $44.26, the initiation price target suggests a potential upside of $10.74 or approximately 24.28% for $DFIN, according to the brokerage firm's view.

Black Diamond Therapeutics Inc. (Nasdaq: BDTX), a biotechnology company, was upgraded by Stifel from Hold to Buy, with the price target raised from $2 to $10. 

Despite $BDTX closing at $5.03 on Thursday, the upgraded price target indicates a potential upside of $4.97 or about 98.81% based on the investment banking firm's analysis.

Pacific Biosciences of California Inc. (Nasdaq: PACB), a provider of genetic sequencing systems, was initiated for coverage by Goldman Sachs with a Buy rating and a price target of $17.

With $PACB closing at $13.12 on Thursday, the stated price target implies a potential upside of $3.88 or approximately 29.57%, based on the investment banking firm' view.

CDW Corporation (Nasdaq: CDW), a provider of technology products and services, received coverage initiation from Citigroup with a Buy rating and a price target of $205.

Based on Thursday's closing price of $180.65, the initiation price target suggests a potential upside of $24.35 or about 13.49% for $CDW, according to Citigroup's assessment.

The potential upsides mentioned for these companies are based on assessments and recommendations from the respective brokerage firms or analysts, reflecting their perspective on each company's future performance. However, it is essential for investors to conduct their own research and consider additional factors before making any investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)